While not all biomarker-positive PTCL patients responded to treatment, this result supports the role of JAK/STAT alterations in T-cell lymphomas, including CTCL. The gene discussed is SOAT1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.